A study based on the “Orencia and Rheumatoid Arthritis” registry, which included 1003 Caucasian patients with RA, showed significant differences in ACPA values between patients with satisfactory and unsatisfactory EULAR responses (75.9% vs. 62.2%: p = 0.001) [51]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.